Sponsor:
Washington University School of Medicine
Code:
NCT06830109
Conditions
Nasal Obstruction
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Oxymetazoline Nasal Spray
Budesonide nasal spray
Brief summary:
Conditions
Nasal Obstruction
Study ID
NCT06830109
Start date
Oct 15, 2024
Status verified date
Sep, 2025
Completion date
Dec 30, 2026
Anticipated
Primary completion date
Dec 30, 2026
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
80 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Treatment
Arms
experimental: budesonide + oxymetazoline,
active comparator: budesonide
Interventions
Oxymetazoline Nasal Spray
Budesonide nasal spray
Primary outcome measure
Central contacts
Locations
Washington University
Recruiting
St Louis, Missouri, United States, 63110
Contacts
Sponsor
Washington University School of Medicine
Last update posted
Sep 11, 2025
Last verified
Sep, 2025
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by Washington University School of Medicine on 2025-09-11.